1. Home
  2. MWG vs GOVX Comparison

MWG vs GOVX Comparison

Compare MWG & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MWG
  • GOVX
  • Stock Information
  • Founded
  • MWG 1988
  • GOVX 2001
  • Country
  • MWG Singapore
  • GOVX United States
  • Employees
  • MWG N/A
  • GOVX N/A
  • Industry
  • MWG Miscellaneous manufacturing industries
  • GOVX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MWG Consumer Discretionary
  • GOVX Health Care
  • Exchange
  • MWG Nasdaq
  • GOVX Nasdaq
  • Market Cap
  • MWG 8.3M
  • GOVX 7.6M
  • IPO Year
  • MWG 2023
  • GOVX N/A
  • Fundamental
  • Price
  • MWG $0.22
  • GOVX $0.76
  • Analyst Decision
  • MWG
  • GOVX Strong Buy
  • Analyst Count
  • MWG 0
  • GOVX 4
  • Target Price
  • MWG N/A
  • GOVX $10.50
  • AVG Volume (30 Days)
  • MWG 42.2K
  • GOVX 1.2M
  • Earning Date
  • MWG 05-27-2025
  • GOVX 07-28-2025
  • Dividend Yield
  • MWG N/A
  • GOVX N/A
  • EPS Growth
  • MWG N/A
  • GOVX N/A
  • EPS
  • MWG N/A
  • GOVX N/A
  • Revenue
  • MWG $31,066,000.00
  • GOVX $6,143,044.00
  • Revenue This Year
  • MWG N/A
  • GOVX N/A
  • Revenue Next Year
  • MWG N/A
  • GOVX N/A
  • P/E Ratio
  • MWG N/A
  • GOVX N/A
  • Revenue Growth
  • MWG N/A
  • GOVX 1943.07
  • 52 Week Low
  • MWG $0.21
  • GOVX $0.43
  • 52 Week High
  • MWG $0.62
  • GOVX $11.18
  • Technical
  • Relative Strength Index (RSI)
  • MWG 35.97
  • GOVX 51.62
  • Support Level
  • MWG $0.21
  • GOVX $0.66
  • Resistance Level
  • MWG $0.25
  • GOVX $0.75
  • Average True Range (ATR)
  • MWG 0.02
  • GOVX 0.05
  • MACD
  • MWG -0.00
  • GOVX 0.01
  • Stochastic Oscillator
  • MWG 11.61
  • GOVX 62.30

About MWG Multi Ways Holdings Limited

Multi Ways Holdings Ltd is a supplier of a wide range of heavy construction equipment for sales and rental in Singapore and the surrounding region. The wide variety of new and used heavy construction equipment for sale and rental by customers range from: earth-moving equipment such as bulldozers, off-terrain dump trucks, excavators and wheel loaders; material-handling equipment such as crawler cranes, rough terrain cranes, scissor lifts, forklifts, boom-lifts and telescopic handlers; road-building equipment such as motor graders, vibrating compactors, asphalt finishers, skid loaders, backhoe loaders, hand rollers and mini excavators; and generators and compressors, such as air compressors, generators, lighting towers and welding machines.

About GOVX GeoVax Labs Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.

Share on Social Networks: